Deal would preserve in-network access to OHSU for most—though not all—members of one of the largest health insurance ...

James Talarico's plan to break up healthcare conglomerates drew instant pushback from CVS, AHIP and the PBM lobby. He and ...

Rhode Island Attorney General Peter Neronha is urging state regulators to reject two insurers’ proposed increases to premiums for individual health plans in 2027. After a July administrative hearing ...

Blue Cross Blue Shield of Michigan is making a change that will effectively cut reimbursements for certain providers this ...

The shots have been approved for people 65 and older, and for younger people with underlying conditions. Others may be able ...

Health systems, investors and industry analysts are increasingly pointing to a common theme when it comes to ASCs: relative to hospitals and health insurers, their financial profile looks ...

Texas Democrat James Talarico unveiled a healthcare plan today with backing from billionaire Mark Cuban, proposing to break ...

APRA's latest quarterly data shows a single quarter that nearly erased Australia's general insurance profits. The reason - ...

A California state senator is pushing legislation that would lower the cost of popular weight loss drugs such as Ozempic and ...

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care.

The No Surprises Act’s arbitration process is once again embroiled in controversy as physician groups speak out on what they say are inflated IDR costs being reported out through recent research.  A ...

A new study from UCLA has found that insurers saw $3,820 lower monthly costs from the use of biosimilars. Cancer patients ...